MedTrace Logo

Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

NCT04097912 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99999

Last updated 2021-11-05

No results posted yet for this study

Summary

This study aims to gather information to what extent patients follow the treatment regimen of low-dose aspirin for primary and secondary prevention of diseases of the heart and blood vessels. Researcher will collect information about the percentage of time a patient has access to the medication, how long patients continue with the medication and of the proportion of patients who switch from dual-antiplatelet therapy (including low-dose aspirin) to a single antiplatelet therapy. The study will make use of secondary healthcare data sources converted in to Observational Medical Outcomes Partnership (OMOP) common data model within the Observational Health Data Sciences and Informatics (OHDSI) network.

Conditions

  • Myocardial Infarction
  • Stroke (Including Ischaemic Stroke and Transient Ischaemic Attack)
  • Unstable Angina
  • Angina
  • Ischaemic Heart Disease

Interventions

DRUG

Acetylsalicylic Acid (Aspirin, BAYE4465)

75-100mg

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2020-11-15
Completion
2020-11-15

Countries

  • Germany
  • United Kingdom

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097912 on ClinicalTrials.gov